Neuroheal Biomedicals was founded by Caty Casas, Ph.D., David Romeo, Ph.D., from the Universitat Autònoma de Barcelona, and Joaquim Forés M.D., Ph.D., from Hospital Clínic de Barcelona. Josep Lluis Falcó, Ph.D., director of GENESIS Biomed is the Chief Executive Officer, responsible for the strategic direction and business development of the company.
Joaquim Forés, M.D
David Romeo, PhD
Josep LLuis Falcó, PhD
Caty Casas, Ph.D. in Biology from the Universitat de Barcelona is an associate professor at the Universitat Autònoma de Barcelona (UAB) and she is a principal investigator in the Neuroplasticity and Regeneration Group of the Institute of Neuroscience at UAB. She has a multidisciplinary formation with a Ph.D. in human molecular genetics in the laboratory of Professor Xavier Estivill, and a Marie-Curie granted postdoctoral research and biotech experience on neurodegenerative diseases at the Centre de Recherche of Sanofi-Aventis in Paris where she presented her first patent. Dr Casas has more than 15 years of outstanding research experience in the field of neurodegenerative processes of motoneurons after traumatic injury with more than 43 peer-reviewed scientific articles, some in high-impact journals and many as corresponding author, with more than 4000 citations, and a total of 6 submitted biomedical patents, half of them licensed. She has been participated in 23 funded Projects, 8 of them as principal investigator, from several national and international agencies, attracting more than one million euros. She was the founder and Chaired of an international network devoted to the translation of knowledge in the autophagy field called TRANSAUTOPHAGY encompassing with more than 300 researches from 30 European and neighbor countries and granted with an H2020-COST Action funding. She is member of SEFAGIA and founder member of a recently granted Spanish Network on Systems Neuroscience. She has received formation in entrepreneurship at the Cambridge University, UK (Cambridge Ignite program), and at the Toulouse Business School in Barcelona.
Joaquim Forés is M.D. (1987), Ph.D. (1992) from UAB, is working as a Senior Consultant at the Orthopedic and Traumatology Unit of the Hospital Clinic de Barcelona, and Vice-Chair of the medical ethic committee at the same Institution. He has been long-term collaborator within the group of Neuroplasticity and Regeneration at the Institut de Neurociències at the UAB with an outstanding contribution in setting-up animal models with microsurgery. He is committed as assessor in clinical issues of the Project. He has participated in more than 61 publications and 4 book chapters, in 25 granted projects, 5 of them as principal investigator, and received an award of investigation (American Society for Surgery of the Hand, 2013). He is also associated professor at the Faculty of Medicine from the Universitat de Barcelona and Bon Samaritaine (Txad, 2012-2018).
David Romeo has a Ph.D. (2017) in Neuroscience from UAB working in the discovery of NeuroHeal within Dr Casas team lab. He investigated the potential of the use of Systems biology approaches and Artificial Neuronal Networks to obtain novel and effective therapies for nerve injuries. He is currently an early-career postdoctoral researcher at the Dr. Franck Oury’s lab at the INSERM in the Institut Necker Enfants-Malades (INEM), in Paris (France). He has published 6 peer-review articles and presented his research in several international and national scientific congresses. He has submitted two patents and participated in courses for entrepeneurship (Generalitat de Catalunya).
Josep Lluís Falcó, Ph.D. from Institut Químic de Sarrià (IQS) and is founder and CEO of Genesis BioMed and Genesis Venture. He has 20 years of experience in the biomedical sector. His experience is based in Healthcare Strategy, Technology Transfer, Fundraising of start-up companies, Business Development, Marketing, Market Access, Reimbursement and Regulatory Affairs. He has worked for big pharma companies (Sanofi), mid-size pharmas (Ferrer Grupo), small biotechs (Hospital spin-off), Tech Transfer Offices (Fundació Bosch i Gimpera) and consulting firms (Antares Consulting and Asphalion). He has also been associate professor at IQS. In the last 4 years, he has been involved in 6 private fundraising processes and he has contributed to raise 33.5 million euros for his clients.